NCT04674839View on ClinicalTrials.gov

The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

September 4, 2020

Study Completion Date

November 20, 2020

Conditions
Microbiota
Interventions
DRUG

MS-20

fermented soymilk product

OTHER

Placebo

No active ingredient

Trial Locations (1)

Unknown

Microbio Group, Taipei

All Listed Sponsors
lead

Microbio Co Ltd

INDUSTRY

NCT04674839 - The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals | Biotech Hunter | Biotech Hunter